Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Ojjaara (momelotinib) is the only approved treatment for newly diagnosed and previously treated myelofibrosis patients i who ...

Anemia, a condition characterized by a reduction in red blood cells or hemoglobin, limits oxygen transport within the body.

Saeed Sadeghi, MD, explores the future treatment landscape for anemia in lower-risk myelodysplastic syndromes (LR-MDS), ...

Many individuals with sickle cell anemia undergoing controlled ovarian hyperstimulation (COH) with oocyte cryopreser ...

Sickle cell anemia requires ongoing, lifelong treatment to improve quality of life and prevent complications. Treatment of sickle cell anemia includes taking measures to treat anemia, prevent ...

Anemia is highly prevalent in patients with chronic heart failure (HF) and is associated with poor clinical outcomes. Multiple mechanisms contribute to anemia in chronic HF, and subnormal ...

The global drug-induced immune hemolytic anemia market, valued at approximately USD 7.8 billion in 2023, is poised for ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...